This premature enthusiasm has more recently given way to caution as the technology has gradually been transferred to humans, with only limited short - term success.3 Finally, since HIV usually enters the body through mucosal surfaces — the vagina and rectum — augmenting an immune response at these portals of entry by using what scientists call mucosal AIDS vaccines might be an additional way to
improve protection against infection.